Identification Of A Plasma Proteomic Signature For Lung Cancer
Posted Date: May 15, 2019
- Investigator: Sandra Starnes
- Type of Study: Drug
This is a clinical research study of an investigational blood testing by the sponsor. The Food and Drug Administration (FDA) considers an investigational test to be a test that is not approved for general use; therefore it is not commercially available. The purpose of this study is to use a new lab
Criteria:
Eligible Patients Must Have A Lung Nodule And Have Been Scheduled For Serial Assessments Or A Surgic
Keywords:
1013-11/12, Blood Test, Lung Cancer, Nodules
For More Information:
Uc Cancer Center
513-584-7698
kastla@ucmail.uc.edu